Your Top 50 most-cited badge

A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.

The article

Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous EGFR -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial

D. Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Wade Goldman, Fedor Vladimirovich Moiseenko, Elena Filippova and 24 more

Rank
20 of 493
Percentile
top 4.1%
Where
Journal of Clinical Oncology, 2024
Citations
181

From the 2024 list, OpenAlex counts as of 2026-10-29.

Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.